Mupirocin cream

Drug Profile

Mupirocin cream

Alternative Names: Bactroban; Bactroban Nasal; Centany

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antibacterials; Carboxylic acids; Epoxy compounds; Esters; Nonanoic acids; Pyrans; Small molecules
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Burn infections; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections; Wound infections

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 25 Nov 2011 Launched for Methicillin-resistant Staphylococcus aureus infections in Russia (Intranasal) before November 2011
  • 25 Nov 2011 Launched for Skin and soft tissue infections in Russia (Topical) before November 2011
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top